Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06)
用于早期检测和预测 HER2 阳性早期乳腺癌患者曲妥珠单抗和/或拉帕替尼诱导的心脏毒性的心脏生物标志物:NeoALTTO 子研究 (BIG 1-06)
期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-017-4628-3
Ponde, Noam; Bradbury, Ian; Lambertini, Matteo; Ewer, Michael; Campbell, Christine; Ameels, Helene; Zardavas, Dimitrios; Di Cosimo, Serena; Baselga, José; Huober, Jens; Izquierdo, Miguel; Fumagalli, Debora; Bozovic-Spasojevic, Ivana; Maetens, Marion; Harbeck, Nadia; Pusztai, Lajos; Berghorn, Michael; Im, Young-Hyuck; Borrego, Manuel Ruiz; Chen, Dar-Ren; Rodeheffer, Richard; Piccart, Martine; Suter, Thomas; de Azambuja, Evandro